Treatment for depression following the 1996 National Depression Screening Day

American Journal of Psychiatry

Volumn 157, Issue 11, 2000, Pages 1867-1869

  Greenfield, S F ^a   Reizes, J M ^a   Muenz, L R ^a   Kopans, B ^a   Kozloff, R C ^a   Jacobs, D G ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; FLUOXETINE; PAROXETINE; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ARTICLE; DEPRESSION; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MENTAL HEALTH SERVICE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOTHERAPY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; CANADA; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INSURANCE, HEALTH; INSURANCE, PSYCHIATRIC; MALE; MASS SCREENING; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; SEVERITY OF ILLNESS INDEX; SEX FACTORS; UNITED STATES;

EID: 0033755819     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.157.11.1867     Document Type: Article

References (4)

1. Who comes to a voluntary depression screening program?
2. Effectiveness of community-based screening for depression
3. A self-rating depression scale